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Massive spreading of the pandemic Coronavirus Disease 2019 (COVID-19) in different 
continents [1, 2], have been observed [3]. Analyses mostly focused on the number of 
cases per country and administrative levels, multiple times without considering the 
relevance of the incidence rates. These help to see the concentration of disease among 
the population in terms of cases per 100,000 inhabitants. Even more, using geographical 
information systems (GIS)-based maps, stakeholders may rapidly analyze changes in the 
epidemiological situation [4-7]. Although the epidemic of COVID-19 caused by the severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in Italy on January 31, 
2020, no reports on the use of GIS-based maps have been published to analyze the 
distinct differences in incidence rates across its regions and provinces during the last 
months. For these reasons, we have developed epidemiological maps of incidence rates 
using official populations, by regions (1st administrative level of the country) and provinces 
(2nd administrative level), for COVID-19 in Italy using GIS. 
  
Surveillance cases data of the cumulative number at March 15, April 18, and June 8, 
2020, officially reported by the Italian health authorities were used to estimate the 
cumulated incidence rates on those dates using reference population data on SARS-CoV-
2 confirmed infections (cases/100,000 pop) and to develop the maps by regions and 
provinces, using the GIS software Kosmo® 3.1, as performed in previous related studies 
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[6, 7]. Starting on March 8, 2020, the region of Lombardy, together with 14 additional 
northern and central provinces, in Piedmont, Emilia-Romagna, Veneto, and Marche, they 
were put under lockdown. On March 10, 2020, the government extended the lockdown 
measures to the whole country. 
 
Up to March 15, 2020, after 44 days of epidemics, 24,053 cases of COVID-19 were 
reported in the country, for a cumulated rate of 39.6 cases/100,000 population, reaching 
174,103 cases during April 18, 2020, for a rate of 286.78, and 232,855 cases during June 
8, 2020, for a rate of 383.56. All the regions of the country have been affected, with rates 
ranging from 59.42 (Calabria) to 947.75 cases/100,000 population (Aosta Valley/Vallée 
d'Aoste) (June 8, 2020) (Figure 1). Higher diversity is found in provinces, where incidence 
rates ranged from 28.23 (Sud Sardegna, Sardinia) to 1,811.37 (Cremona, Lombardy) 
(June 8, 2020) (Table 1). At Lombardy are located five of the top ten provinces with higher 
incidence rates (Table 1) (Figure 1), with considerable increases and changes from March 
15, 2020, to June 8, 2020, in approximately three months (Figure 1) (Table 1). Cremona 
(Lombardy), Piacenza (Emilia-Romagna), and Lodi (Lombardy) have become in the 
geographic core of the cumulated incidence rate of COVID-19 in the north of the country 
and Italy (Figure 1).  
 
From the GIS-based maps, it is clear that spreading in the country is occurring from north 
regions and provinces such as Lombardy. On March 15, 2020, most of the southern 
regions were not affected (Figure 1), but approximately a month later, all of them reported 
COVID-19 cases (Figure 1), including the insular regions of Sicily and Sardinia. While the 
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change between April 18 and June 8, has been 33%, there is still a concern in the country, 
mainly because, in this time, the number of deaths has reached over 34,000 deaths 
(14.6%).  
 
Italy reached the top of countries with the highest number of reported COVID-19 cases, 
now is the ninth country in cumulated cases. It is the fourth in the European region, after 
Russia, the United Kingdom, and Spain. Italy represented one of the most significant 
sources of imported cases for other continents, as is the case of Latin America, that 
received their first cases from Milan, Lombardy [8-10].   
 
Patient 1 of Italy (it was not possible to find patient 0) was discovered on February 20, 
2020, when a 38-year-old man from the city of Codogno had shown up at the hospital. 
Since that date, two large clusters of outbreaks have spread first in Northern Italy, later 
all over the country (Figure 1) [11]. Cases are multiplying, and the national healthcare 
system is collapsing [12-14]. Many regions are increasing intensive care beds, 
revolutionizing entire hospital wards. In Italy, the coordination of the swabs is managed 
regionally. Once the epidemic began, for example, the Veneto region started immediately 
with active surveillance, i.e., on asymptomatic, and this contained the spread of the virus 
compared to other Northern Regions. 
 
The health system is indeed regionalized, and dispositions of the Ministry of Health are 
translated into multiple regional decrees and regulations, often at different timings [15]. 
Many regions, for example, adopted evolving criteria for testing and diagnosis, according 
6 
 
to dispositions from the central Government, but also to test capacity, which was heavily 
reliant on the availability of reagents. Samples were collected either in healthcare 
facilities, in provisional collection points, or even in people's houses, depending on the 
region and the phase of the pandemic. The epitome of these differences is the two most 
heavily affected regions, Lombardy and Veneto. Lombardy hospitalized, even cases with 
relatively modest symptoms, causing numerous nosocomial outbreaks (9% of infections 
were among health professionals until March).  Veneto, instead, deployed widespread 
testing since the beginning, maintaining disease management as much as possible at the 
primary health care level [15].  
 
The healthcare workers are facing COVID-19 pulling 12 hours shifts in critical situations 
with minimal to non-existent personal protective equipment (PPE) [12-14]. Lacking PPE 
led both many healthcare workers to become COVID-19 positive (7,145), and to the death 
of several doctors (51; about 9% of the total cases; March 27, 2020) [11]. 
 
As observed in the GIS-based maps, the COVID-19 spreading in the country has been 
significant and moving from north to south across the time, with provinces reaching more 
than 1,000 cases per 100,000 inhabitants (Figure 1) [12-14]. Differences in the incidence 
by regions would be related to different social and economic factors. Such as people who 
travel abroad, for whom there is a sharp difference between northern regions (about 26% 
of travelers) and central and southern regions (about 19%). Or net income at the 
household level, which is ranging from 35,000€ in the North-east to 26,000€ in the South 
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[16]. Additionally, as has been recently suggested, climatic conditions could also influence 
the transmission of SARS-CoV-2 [17]. 
 
Testing capacity increased over time. While some degree of ascertainment bias is 
inevitable, the number of swabs performed nationally stabilized around 70,000 per day in 
mid-April when the peak in the number of active cases was registered (Figure 1). From 
that point onwards, daily cases only decreased, consistently with the impact of the 
lockdown imposed in early March. Besides, and most importantly, while it is true that the 
epidemic might have gone undetected for some time before Case 1 was discovered in 
Codogno, the growth in ICU beds demand for subjects with respiratory failure that ensued 
in the following weeks is most likely explained by a substantial increase of cases. 
 
Considering the limitations of diagnostics and the asymptomatic cases, these figures 
would be many times more. Further characterization studies should include multiple GIS-
based maps with other variables at the regions and provinces levels such as deaths, 
hospitalizations, and ICU rates per population to understand better the critical situation of 
the country and its administrative levels. 
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Table 1. Top ten provinces by incidence rate (cases/100,000 inhabitants), of COVID-19, Italy, on March 15, April 18, and 
June 8, 2020. 
 
Region Province Populationa 
Casesb Incidence Ratesc 
15-Mar 18-Apr 8-Jun 15-Mar 18-Apr 8-Jun 
Lombardy Cremona 358955 1792 5407 6502 499.23 1506.32 1811.37 
Emilia-Romagna Piacenza 287152 1012 3299 4506 352.43 1148.87 1569.20 
Lombardy Lodi 230198 1320 2714 3502 573.42 1178.99 1521.30 
Lombardy Bergamo 1114590 3416 10629 13609 306.48 953.62 1220.99 
Lombardy Brescia 1265954 2473 11758 15070 195.35 928.79 1190.41 
Lombardy Pavia 545888 722 3536 5418 132.26 647.75 992.51 
Aosta Valley / Vallée d'Aoste Aosta Valley / Vallée d'Aoste 125666 57 1073 1191 45.36 853.85 947.75 
Piedmont Alessandria 421284 207 2752 3968 49.14 653.24 941.88 
Emilia-Romagna Reggio nell'Emilia 531891 185 4217 4962 34.78 792.83 932.90 
Piedmont Asti 214638 87 1038 1857 40.53 483.60 865.18 
aFrom ISTAT. "Italian National Institute of Statistics - Resident Population." Demographic Statistics. Accessible at http://demo.istat.it/. Accessed on 8 June 2020.  
bItalian Civil Protection Department [COVID-19 Italy - Situation monitoring]. Accessible at 
http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1. Accessed on 8 June 2020.  





Figure 1. COVID-19 situation in Italy, on March 15, April 18, and June 8, 2020, by regions and provinces. 
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